How to create sustainable market access to advanced therapies? KU Leuven
Advanced therapies are groundbreaking medicines that may cure diseases. However, there is still uncertainty about their long-term impact on patient health and their high price threatens to make them unaffordable. In Europe, 17 of such therapies have been approved to date, but many more are coming in the next few years. How can we ensure patient access to advanced therapies?
This project will address four key challenges. First, ...